This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 Jul 7;43(26):2493-2495.

doi: 10.1093/eurheartj/ehab814.

Reducing mortality by myocardial T2* cardiovascular magnetic resonance at national level

Mark A Westwood¹, Dudley J Pennell¹

Affiliations

PMID: 34907427
DOI: 10.1093/eurheartj/ehab814

Editorial

Reducing mortality by myocardial T2* cardiovascular magnetic resonance at national level

Mark A Westwood et al. Eur Heart J. 2022.

. 2022 Jul 7;43(26):2493-2495.

doi: 10.1093/eurheartj/ehab814.

Authors

Mark A Westwood¹, Dudley J Pennell¹

Affiliation

¹ CMR Unit, Royal Brompton Hospital, London, UK.

PMID: 34907427
DOI: 10.1093/eurheartj/ehab814

No abstract available

PubMed Disclaimer

Comment on

National networking in rare diseases and reduction of cardiac burden in thalassemia major.
Pepe A, Pistoia L, Gamberini MR, Cuccia L, Lisi R, Cecinati V, Maggio A, Sorrentino F, Filosa A, Rosso R, Messina G, Missere M, Righi R, Renne S, Vallone A, Dalmiani S, Positano V, Midiri M, Meloni A. Pepe A, et al. Eur Heart J. 2022 Jul 7;43(26):2482-2492. doi: 10.1093/eurheartj/ehab851. Eur Heart J. 2022. PMID: 34907420

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems